The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
After a relatively mild and quiet night, an episode of rain for many of us tomorrow.
The 34-year-old from Coulsdon in Surrey died during the private party in Headley in the early hours of Monday, Surrey Police said.
The Home Office made the arrests at various restaurants across London on July 4.